Using a plasmid-DNA vaccine encoding an irrelevant antigen (TEM1) not expressed by 4T1 cells (11), we proved that solely T cells primed by the FoxL2-TT vaccination, and not by irrelevant antigenic portions of the vector, actively recognize the FOXL2-expressing tumor. The gene discussed is FOXL2; the disease is neoplasm.